Resident 360 Study Plans on AMBOSS
Find all Resident 360 study plans on AMBOSS
Fast Facts
A brief refresher with useful tables, figures, and research summaries
Late Effects of Cancer Treatment
Improvement in the treatment of childhood cancer has resulted in a growing number of childhood cancer survivors. Data from the United States Surveillance Epidemiology and End Results Cancer Statistics Review demonstrated a 5-year survival of 60% among children diagnosed before 20 years of age from 1975 to 1977 compared with 85% among those diagnosed from 2009 to 2015.
Therapy-related complications: The growing number of childhood cancer survivors has led to the emergence of long-term adverse effects from childhood cancer and treatment. The link below summarizes some potential therapy-related complications.
Potential Therapy-Related Complications by Organ System
Guidelines: As the number of childhood cancer survivors is expected to increase secondary to improvement in therapies, it is imperative that primary care providers become familiar with the care of these patients. The Children’s Oncology Group (COG) has published Long-Term Follow-Up (LTFU) guidelines to provide physicians with screening tools and individualized screening recommendations based on treatments a patient might have received. These guidelines are updated every few years as new evidence emerges.
Research
Landmark clinical trials and other important studies
Gibson TM et al. Lancet 2018.
This study demonstrates that secondary to modification of childhood cancer treatments over the past few decades, the proportion of survivors with serious chronic health conditions has decreased; however, survivors continue to be at risk of late effects, necessitating lifelong follow-up care.
Armstrong GT et al. N Engl J Med 2016.
The strategy of lowering therapeutic exposure has contributed to an observed decline in late mortality among 5-year survivors of childhood cancer.
Oeffinger KC et al. N Engl J Med 2006.
This landmark study shows the high prevalence of chronic health conditions in survivors of childhood cancer treatment between 1970 and 1980.
Bhatia S et al. N Engl J Med 1996.
This study identified risk factors for second malignant neoplasms of the breast in female survivors of Hodgkin lymphoma, specifically radiation therapy. This study and the Late Effects Study Group laid the groundwork for examination of both the epidemiology of late effects as well as the genetic underpinnings of them.
Reviews
The best overviews of the literature on this topic
Berkman AM et al. Curr Opin Pediatr 2023.
Chow EJ et al. Semin Oncol 2020.
Landier W et al. J Clin Oncol 2018.
Brinkman TM et al. J Clin Oncol 2018.
Bhatia S et al. Blood 2017.
Bhatia S. Cancer 2015.
Armenian SH and Robison LL. Curr Opin Pediatr 2013.
Guidelines
The current guidelines from the major specialty associations in the field
Kalsbeek RJ et al. Eur J Cancer 2021.
Children’s Oncology Group 2018.
Chow EJ et al. Biol Blood Marrow Transplant 2016.